Elawar Anwar, Livache Audrey, Patault Stéphanie, Vila Damien
Dr. Elawar, Ms. Livache, and Ms. Patault are with the Aesthetic Dermatological Laser Center in Marseille, France.
Mr. Vila is with the Faculty of Medicine of Montpellier-Nîmes at the University of Montpellier in Montpellier, France.
J Clin Aesthet Dermatol. 2023 Feb;16(2):24-28.
Photobiomodulation therapy (PBMT) can significantly reduce inflammation and relieve pain, including postoperative pain and edema. The study aimed to evaluate the performance of a photobiomodulation-based device that includes a static magnetic field (SMF) to treat laser- or intensive and fractional radiofrequency-related side effects, such as pain, redness, and edema in patients treated for different dermatological conditions.
The study had a prospective, non-randomized, single-center design. Male and female patients aged 18 years or older underwent one or two PBMT-SMF (anti-inflammatory or anti-edematous) sessions on the same day, once or twice a week, after laser or radiofrequency facial treatments due to various dermatological disorders. Variables and efficacy assessments were pain, redness, edema, and their reduction from baseline to the last visit.
Twenty-seven patients were included, seven (25.9%) men and 20 (74.1%) women, with a mean (SD) age of 43.7 (14.1) years. Seven (25.9%) patients were treated with radiofrequency, and 20 (74.1%) patients with a vascular laser (three [15%] for angioma, two [10%] for scars, three [15%] for erythrosis, and 12 [60%] for rosacea). After the PBMT-SMF protocol, overall mean pain reduction was 40 percent, and redness and edema reduction were shown by the pictures taken before and after the PBMT-SMF procedure.
The primary limitations were the small number of patients and no quantitative variables for redness and edema.
PBMT-SMF reduced edema and inflammation after treatment with lasers or intensive or fractional radiofrequency for facial conditions, and probably, analgesic and anti-inflammatory drugs.
光生物调节疗法(PBMT)可显著减轻炎症并缓解疼痛,包括术后疼痛和水肿。本研究旨在评估一种基于光生物调节的设备的性能,该设备包含静磁场(SMF),用于治疗激光或强脉冲光及非剥脱性射频治疗相关的副作用,如不同皮肤病治疗患者出现的疼痛、发红和水肿。
本研究采用前瞻性、非随机、单中心设计。18岁及以上的男性和女性患者,因各种皮肤病接受面部激光或射频治疗后,于同一天接受一或两次PBMT-SMF(抗炎或抗水肿)治疗,每周一次或两次。变量和疗效评估指标为疼痛、发红、水肿,以及从基线到最后一次就诊时这些指标的减轻情况。
共纳入27例患者,其中男性7例(25.9%),女性20例(74.1%),平均(标准差)年龄为43.7(14.1)岁。7例(25.9%)患者接受了射频治疗,20例(74.1%)患者接受了血管激光治疗(3例[15%]治疗血管瘤,2例[10%]治疗瘢痕,3例[15%]治疗红斑,12例[60%]治疗玫瑰痤疮)。经过PBMT-SMF方案治疗后,总体平均疼痛减轻了40%,PBMT-SMF治疗前后拍摄的照片显示发红和水肿有所减轻。
主要局限性在于患者数量较少,且发红和水肿没有定量变量。
PBMT-SMF可减轻激光、强脉冲光或非剥脱性射频治疗面部疾病后出现的水肿和炎症,可能还可替代镇痛和抗炎药物。